BDBM464262 3-(4-(1H-pyrazol-4- yl)phenyl)-1-(3- fluoro-2- methylbenzyl)-8-(2- hydroxyethyl)-1,3,8- triazaspiro[4.5]decan- 2-one::US10787450, Example 143

SMILES Cc1c(F)cccc1CN1C(=O)N(CC11CCN(CCO)CC1)c1ccc(cc1)-c1cn[nH]c1

InChI Key InChIKey=MRLHWLRQPXUJJR-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 464262   

TargetRho-associated protein kinase 2(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM464262(3-(4-(1H-pyrazol-4- yl)phenyl)-1-(3- fluoro-2- met...)
Affinity DataIC50: <3nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent